Nifedipine: Nursing Drug Guide, Hypotension & NCLEX Review

Nifedipine immediate-release capsules are marketed as Procardia and generic nifedipine capsules. Extended-release tablets include Procardia XL and generic nifedipine extended-release products. Older brand names such as Adalat may still appear on home medication lists. IR capsules and ER tablets are not interchangeable—confirm formulation during medication reconciliation because dosing frequency, onset, and maximum daily dose differ.

Do not confuse nifedipine with other dihydropyridines such as amlodipine or with non-dihydropyridine agents that slow AV conduction. Nifedipine primarily lowers vascular resistance and can cause reflex tachycardia rather than bradycardia.

Per Procardia XL and nifedipine extended-release labeling, ER nifedipine is indicated for hypertension. Immediate-release nifedipine capsules are indicated for vasospastic and chronic stable angina. Some patients with hypertensive urgency historically received short-acting nifedipine, but rapid BP drops without monitoring are no longer recommended—verify current institutional protocol before administering any formulation for acute blood pressure elevation.

↔On a small screen, swipe or scroll sideways to see the full table.

Nifedipine blocks L-type calcium channels in arterial smooth muscle, causing peripheral vasodilation and reduced systemic vascular resistance. Unlike verapamil or diltiazem, nifedipine has minimal direct effect on AV nodal conduction at therapeutic doses—reflex sympathetic activation may increase heart rate when blood pressure falls abruptly.

Extended-release formulations use a gastro-intestinal therapeutic system (GITS) or similar matrix to release drug slowly over hours. Crushing or chewing bypasses this control and delivers a bolus equivalent to multiple doses—a common cause of dangerous hypotension on the unit.

Onset, peak, duration, and half-life (ER labeling)

↔On a small screen, swipe or scroll sideways to see the full table.

Dosing depends on formulation. Titrate ER products every 7–14 days per Procardia XL labeling. Rapid dose escalation or substituting IR for ER without a new order increases hypotension risk.

Extended-release titration (hypertension)

↔On a small screen, swipe or scroll sideways to see the full table.

Missed dose (oral): Take when remembered unless near the next dose—do not double. After a missed day, reassess blood pressure before restarting if the patient felt dizzy or had low readings at home.

Pretreatment checks

• Obtain blood pressure supine and standing using proper blood pressure measurement and orthostatic blood pressure technique during titration
• Confirm formulation: IR capsule versus ER tablet—verify against prescriber order and pharmacy label
• Screen for grapefruit or grapefruit juice in diet or supplements
• Reconcile beta-blockers and other antihypertensives on the MAR
• Review hold parameters and allergy status

Contraindications and cautions (labeling)

• Known hypersensitivity to nifedipine
• Use caution in severe hypotension, aortic stenosis, and heart failure—negative inotropic effects possible
• Immediate-release capsules not established for hypertension monotherapy in all regions—follow local prescribing practice
• Gastrointestinal obstruction or narrowing may affect ER tablet passage—consult prescriber if swallowing difficulty

Important warnings

• Hypotension: Symptomatic BP drops can occur at initiation and after titration
• Formulation integrity: ER tablets must be swallowed whole—crushing causes dose dumping
• Grapefruit: Co-administration can approximately double AUC and Cmax
• Beta-blocker combination: May cause severe hypotension and conduction disturbances per labeling
• Reflex tachycardia: May mask evolving hypotension—assess symptoms, not rate alone

Important interactions

↔On a small screen, swipe or scroll sideways to see the full table.

Oral ER tablets: Swallow Procardia XL and generic nifedipine ER tablets whole with water on an empty stomach or with a light meal per labeling—do not bite, divide, or crush. Tablet shell may appear in stool; this is expected with the GITS delivery system.

Oral IR capsules: May be swallowed whole or punctured and contents squeezed onto soft food per Procardia capsule labeling—still a different product from ER tablets with distinct dosing.

• Follow safe medication administration rights; independent double-check ER versus IR
• Give ER at the same time each day to maintain steady blood levels
• Assist patients at fall risk when dizziness appears after dosing
• Do not substitute ER for IR or vice versa without a new prescriber order and pharmacy verification

• Gradual reduction in blood pressure over days to weeks on ER therapy without symptomatic hypotension
• Decreased angina frequency on IR therapy when prescribed for coronary vasospasm
• Patient remains alert and oriented with adequate urine output and mental status
• Mild ankle swelling may occur—distinguish from perfusion failure
• Excessive dizziness, syncope, or reflex tachycardia with low BP is not an acceptable response—hold and notify prescriber

Rapid vasodilation from formulation errors or interactions can collapse perfusion within minutes. Escalate when orthostatic or syncope cues appear.

• Syncope, near-fainting, or systolic BP below 90 mmHg after oral dose—hold nifedipine and notify prescriber
• Hypotension after patient chewed or crushed an ER tablet—urgent escalation and perfusion monitoring
• Severe dizziness with standing BP drop greater than 20 mmHg systolic from baseline
• New or worsening angina or chest pain suggesting ischemia despite BP reduction
• Pulmonary edema or rapid weight gain suggesting heart failure decompensation

↔On a small screen, swipe or scroll sideways to see the full table.

Nifedipine overdose may cause marked hypotension, reflex tachycardia, loss of consciousness, and cardiovascular collapse. There is no specific antidote. Hemodialysis is not beneficial per labeling.

Supportive management (labeling)

• Cardiovascular monitoring with frequent blood pressure and heart rate assessment
• IV fluids when appropriate for hypovolemia
• Vasopressors such as dopamine or norepinephrine for refractory hypotension
• IV calcium (chloride or gluconate) may improve myocardial contractility in selected cases—monitor for hypercalcemia
• Gastrointestinal decontamination when oral overdose and timing allow
• Contact local poison control or medical toxicology services per facility protocol

• Nifedipine vs nicardipine / nimodipine—all calcium channel blockers but different indications, routes, and monitoring
• Procardia (IR) vs Procardia XL (ER)—classic IR/ER mix-up; TID capsules versus once-daily tablets
• Nifedipine vs felodipine / amlodipine—verify generic name on MAR, not “-dipine” shorthand alone
• Strength confusion—ER 30, 60, 90 mg and IR 10 mg capsules require independent double-check
• Crush error—ER tablets placed in crushing devices; educate staff that ER nifedipine is swallow-whole only

↔On a small screen, swipe or scroll sideways to see the full table.

↔On a small screen, swipe or scroll sideways to see the full table.

Monitor

• Blood pressure supine and standing during titration and after dose changes
• Heart rate and symptoms (dizziness, chest pain, edema)
• Electrocardiogram (ECG) when beta-blocker overlap or syncope occurs
• Intake of grapefruit, alcohol, and new interacting medicines
• Signs of heart failure or worsening angina

Document

• Formulation (IR vs ER), dose, time, and pre-dose orthostatic vitals
• Hold events with prescriber notification and response
• Patient teaching on swallow-whole ER tablets and grapefruit avoidance
• Pharmacy consultation for formulation changes or interaction checks

• Take ER tablets at the same time daily; swallow whole—never chew, crush, or split
• Avoid grapefruit and grapefruit juice unless prescriber and pharmacist approve an exception
• Rise slowly from sitting or lying; report dizziness, fainting, or swelling
• Do not double a missed dose; contact clinician for guidance
• Tell all clinicians about nifedipine before starting new medicines, including over-the-counter products
• Contact local poison control or toxicology services per facility guidance if too many tablets were taken

Do not give and contact the prescriber/pharmacist when:

Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.

Practice NCLEX-style clinical judgment practice for nifedipine using a tabbed case (MAR, labs, vitals, nursing notes), then priority action, cue recognition, trend interpretation, documentation cloze, beta-blocker interaction judgment, and matrix urgency sorting—recognise cues → analyse → prioritise → act → evaluate outcomes.

This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.

• Editorial Policy
• Medical Review Process
• Disclaimer

Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.